Mayapada Hospital and RSPAD Launch Strategic Stem Cell Therapy Partnership

Collaboration Strengthens Regenerative Medicine Capabilities

Mayapada Hospital, part of Mayapada Healthcare (IDX:SRAJ), has entered into a significant collaboration with Rumah Sakit Pusat Angkatan Darat (RSPAD) Gatot Soebroto to advance stem cell therapy services through research-driven integration. The partnership was formalized through a Memorandum of Understanding signing ceremony between Navin Sonthalia, President Director & CEO of Mayapada Healthcare, and Mayor Jenderal TNI dr. Ichsan Firdaus, Head of RSPAD Gatot Soebroto, on December 2, 2025.

Comprehensive Collaboration Framework

The collaboration encompasses multiple strategic areas including education development, enhancement of human resource competencies, and community service initiatives across various Mayapada Hospital locations in Jakarta Selatan (Lebak Bulus), Kuningan, Tangerang, Bogor, and Bandung. This comprehensive approach aims to establish a robust ecosystem for regenerative medicine in Indonesia.

Strengthening Industry Position

Navin Sonthalia emphasized that the collaboration with RSPAD enables the integration of RSPAD's expertise with Mayapada Hospital's service readiness, including the involvement of certified doctors in research-based stem cell therapy practices. The synergy is expected to enhance Mayapada Hospital's capabilities in handling complex cases across various medical specialties including orthopedics, neurology, immunology, and hematology.

Implementation and Service Development

Mayapada Hospital Bandung (MHBD) has already implemented stem cell therapy services under RSPAD's supervision since October 2, 2024, serving as a pioneer in modern regenerative treatment approaches. The service is supported by a multidisciplinary team of specialists in orthopedics, medical rehabilitation, dermatology, neurology, and related fields, operating under comprehensive clinical protocols aligned with scientific guidelines and health regulations.

Future Prospects and Commitments

Chief of Medical Officer at Mayapada Healthcare, dr. Dini Handayani, highlighted that this collaboration strengthens Mayapada Hospital's position as a responsible center for stem cell therapy development. The partnership with RSPAD experts will help standardize practices, enhance clinical accuracy, and ensure adherence to quality and patient safety principles.

Mutual Benefits and National Impact

The Head of RSPAD Gatot Soebroto, Mayor Jenderal TNI dr. Ichsan Firdaus, welcomed the collaboration, stating it reinforces both institutions' commitment to advancing national healthcare innovation and quality. The synergy is expected to yield significant benefits for medical knowledge development and community service.